Is Myocardial Revascularization Really Necessary in Patients With ≥50-70% Coronary Stenosis Undergoing Valvular Surgery?
- Conditions
- Coronary Artery DiseaseHeart Valve Diseases
- Registration Number
- NCT05836467
- Lead Sponsor
- Michele De Bonis
- Brief Summary
It is well documented in the literature that myocardial revascularization during valve surgery increases the risk of early mortality and morbidity.
According to the most recent version of the European Guidelines, the possibility of myocardial revascularization via coronary artery bypass should be evaluated in patients with an indication for surgical treatment of heart valve disease but with coronary artery stenosis ≥ 50-70%.
In this study, patients hospitalized for surgical heart valve disease, with occasional pre-operative finding of ≥ 50-70% coronary artery stenosis, without angina, are examined. After interdisciplinary discussion in the Heart Team, it was decided not to treat coronary artery disease during valve surgery. The aim is to evaluate the short and medium-term results of this "conscious omission".
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 77
- adult patients
- Presence of valve disease of surgical interest.
- Occasional pre-operative finding of coronary stenosis >= 50-70%.
- angina
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Survival through study completion, a minimum of 18 months Percutaneous revascularization risk through study completion, a minimum of 18 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
IRCCS Ospedale San Raffaele - Cardiac Surgery Department
🇮🇹Milan, Italy